Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

NCT00190034 ↗

Phase 4 Suspended 60 enrolled Far Eastern Memorial Hospital Synmosa Biopharma Corp. · collab

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether N-acetylcysteine is effective in the prophylaxis of post-cardiopulmonary bypass acute renal impairment.

Timeline

Start: 2005-01
Primary completion: —
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	N-acetylcysteine	Small molecule	600 mg	Oral

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

Summary

Timeline

Drugs

Indications